# CEBIOTEX

Source: https://onco.cc/companies/cebiotex/  
OnCo record `cebiotex` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CEBIOTEX is a Spain-based biotechnology company running 2 late-stage cancer trials of CEB-01 in pancreatic ductal adenocarcinoma.

## Summary

CEBIOTEX, based in Barcelona, Spain, is a biotechnology company. Cebiotex is a biotechnology company that uses proprietary nanofibre engineering to deliver anti-tumour agents directly at surgical sites for local, post-surgical cancer therapy. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing CEB-01 in pancreatic ductal adenocarcinoma. The largest, NCT06986811 (CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours), plans to enrol 60 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Barcelona
- Type: biotech
- Website: https://www.cebiotex.com

## Sources

- Official website: https://www.cebiotex.com
- ClinicalTrials.gov: trials led by CEBIOTEX: https://clinicaltrials.gov/search?lead=CEBIOTEX

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)
- trials: [CEB-01 in Locally Resectable Pancreatic Cancer](https://onco.cc/trials/nct06538857/), [CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours](https://onco.cc/trials/nct06986811/)

---
JSON: https://onco.cc/api/v1/entities/cebiotex.json